Literature DB >> 18331233

RAGE in diabetic nephropathy.

Hiroshi Yamamoto1, Takuo Watanabe, Yasuhiko Yamamoto, Hideto Yonekura, Seiichi Munesue, Ai Harashima, Kazuyo Ooe, Sharmin Hossain, Hidehito Saito, Naho Murakami.   

Abstract

As is diabetes itself, diabetic angiopathy is a multi-factorial disease. Advanced glycation endproducts (AGE) cause vascular cell derangement characteristic of diabetes, and this is mainly mediated by their interaction with receptor for AGE (RAGE). When made diabetic, RAGE-overexpressing transgenic mice exhibited exacerbation of the indices of nephropathy, and this was prevented by the inhibition of AGE formation. On the other hand, RAGE-deficient animals showed amelioration of diabetic nephropathy. Accordingly, AGE and RAGE should be regarded as environmental and cellular accounts and as a potential therapeutic target for diabetic nephropathy. In effect, substances that inhibit the formation of AGE, break preformed AGE, change metabolic flows away from glycation, antagonize RAGE, and capture RAGE ligands have been proven as effective remedies against this life-threatening disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18331233     DOI: 10.2174/156652407783220769

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  10 in total

1.  Receptor for advanced glycation end products: its role in Alzheimer's disease and other neurological diseases.

Authors:  Lih-Fen Lue; Douglas Gordon Walker; Sandra Jacobson; Marwan Sabbagh
Journal:  Future Neurol       Date:  2009

2.  An angiotensin II type 1 receptor blocker prevents renal injury via inhibition of the Notch pathway in Ins2 Akita diabetic mice.

Authors:  Masaya Koshizaka; Minoru Takemoto; Seiya Sato; Hirotake Tokuyama; Masaki Fujimoto; Emiko Okabe; Ryoichi Ishibashi; Takahiro Ishikawa; Yuya Tsurutani; Shunichiro Onishi; Morito Mezawa; Peng He; Satoshi Honjo; Shiro Ueda; Yasushi Saito; Koutaro Yokote
Journal:  Exp Diabetes Res       Date:  2012-01-29

Review 3.  Regulation of RAGE for attenuating progression of diabetic vascular complications.

Authors:  Myat Thu Thu Win; Yasuhiko Yamamoto; Seiichi Munesue; Hidehito Saito; Dong Han; So Motoyoshi; Tarek Kamal; Takuro Ohara; Takuo Watanabe; Hiroshi Yamamoto
Journal:  Exp Diabetes Res       Date:  2011-10-29

4.  Selective Inhibition on RAGE-binding AGEs Required by Bioactive Peptide Alpha-S2 Case in Protein from Goat Ethawah Breed Milk: Study of Biological Modeling.

Authors:  Fatchiyah Fatchiyah; Ferlany Hardiyanti; Nashi Widodo
Journal:  Acta Inform Med       Date:  2015-04-14

Review 5.  Controlling the receptor for advanced glycation end-products to conquer diabetic vascular complications.

Authors:  Yasuhiko Yamamoto; Hiroshi Yamamoto
Journal:  J Diabetes Investig       Date:  2012-03-28       Impact factor: 4.232

6.  Preventive Effect of Salicylate and Pyridoxamine on Diabetic Nephropathy.

Authors:  Tarek Kamal Abouzed; Seiichi Munesue; Ai Harashima; Yusuke Masuo; Yukio Kato; Khaled Khailo; Hiroshi Yamamoto; Yasuhiko Yamamoto
Journal:  J Diabetes Res       Date:  2016-11-30       Impact factor: 4.011

7.  Effects of insulin-loaded chitosan-alginate nanoparticles on RAGE expression and oxidative stress status in the kidney tissue of rats with type 1 diabetes.

Authors:  Shirin Heidarisasan; Nasrin Ziamajidi; Jamshid Karimi; Roghayeh Abbasalipourkabir
Journal:  Iran J Basic Med Sci       Date:  2018-10       Impact factor: 2.699

Review 8.  Oxytocin Dynamics in the Body and Brain Regulated by the Receptor for Advanced Glycation End-Products, CD38, CD157, and Nicotinamide Riboside.

Authors:  Haruhiro Higashida; Kazumi Furuhara; Olga Lopatina; Maria Gerasimenko; Osamu Hori; Tsuyoshi Hattori; Yasuhiko Hayashi; Stanislav M Cherepanov; Anna A Shabalova; Alla B Salmina; Kana Minami; Teruko Yuhi; Chiharu Tsuji; PinYue Fu; Zhongyu Liu; Shuxin Luo; Anpei Zhang; Shigeru Yokoyama; Satoshi Shuto; Mizuki Watanabe; Koichi Fujiwara; Sei-Ichi Munesue; Ai Harashima; Yasuhiko Yamamoto
Journal:  Front Neurosci       Date:  2022-07-07       Impact factor: 5.152

9.  Clinical Study of MEBO Combined with Jinhuang Powder for Diabetic Foot with Infection.

Authors:  Hong-Bo Zhan; Qing-Qing Sun; Lei Yan; Jia Cai
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-13       Impact factor: 2.629

10.  The receptor for advanced glycation end-products (RAGE) is only present in mammals, and belongs to a family of cell adhesion molecules (CAMs).

Authors:  Luca Sessa; Elena Gatti; Filippo Zeni; Antonella Antonelli; Alessandro Catucci; Michael Koch; Giulio Pompilio; Günter Fritz; Angela Raucci; Marco E Bianchi
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.